Mike is a co-Principal Investigator of Psychedelic clinical trials and adjunct teaching faculty in Johns Hopkins University. He is currently pursuing MD/PhD in Neuroscience focused on contribution of microbiota and immune response on pathogenesis of depressive disorders.